Search - tctmd.com

Displaying 581 - 600 of 636

Sort: Relevancy | Date

Presentation

Percutaneous LAA Suture Ligation Using the LARIAT Device in Patients with A-fib

Presenter: K. Bartus

October 11, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

July 31, 2012

Presentation

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

Presenter: L. Di Biase

July 30, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

Presentation TVT 2012

Tips and Tricks of LAA Occlusion Using the Amplatzer Cardiac Plug

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

The Wavecrest: Device Iterations and Clinical Studies

Presenter: Brian Whisenant

June 05, 2012

Presentation TVT 2012

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

Presenter: Saibal Kar

June 05, 2012

Presentation TVT 2012

The SentreHeart: Device Design, Procedure, and Clinical Results

Presenter: Steven Yakubov

June 05, 2012

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Presentation TVT 2012

The Evolving Standard of Care: Atrial Fibrillation Ablation

Presenter: Shephal Doshi

June 05, 2012

Presentation TVT 2012

The Essential Role of CT Planning and TEEGuidance to Optimize Device Deployment

Presenter: John Carroll

June 05, 2012

Presentation TVT 2012

The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment

Presenter: John Carroll

June 05, 2012

Presentation TVT 2012

The Amplatzer Cardiac Plug Clinical Studies Program: Perspectives, New Insights, and Future Directions

Presenter: Josep Rodes-Cabau

June 05, 2012

Presentation TVT 2012

Targeted Transseptal with TEE: For LAA Occlusion

Presenter: 204127|Scott Lim

June 05, 2012

Advertisement

Percutaneous LAA Suture Ligation Using the LARIAT Device in Patients with A-fib

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

Does the Left Atrial Appendage Morphology Correlate with Stroke Risk in Patients with A-fib?

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Tips and Tricks of LAA Occlusion Using the Amplatzer Cardiac Plug

The Wavecrest: Device Iterations and Clinical Studies

The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions

The SentreHeart: Device Design, Procedure, and Clinical Results

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

The Evolving Standard of Care: Atrial Fibrillation Ablation

The Essential Role of CT Planning and TEEGuidance to Optimize Device Deployment

The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment

The Amplatzer Cardiac Plug Clinical Studies Program: Perspectives, New Insights, and Future Directions

Targeted Transseptal with TEE: For LAA Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content